Precision medicine in allergic diseasefood allergy, drug allergy, and anaphylaxisPRACTALL document of the European academy of allergy and clinical immunology and the American Academy of Allergy, Asthma and Immunology
345 Co-activator involvement in different cancers A rampant occurrence With the rising burden of cancer, it has become imperative to develop new therapeutic approaches to curb disease progression
The gut barrier damage and microbiota dysbiosis induced by microplastics provide a theoretical basis for the application of probiotics, prebiotics, tight-junction modulators, and topical barrier protectants [155]
The evidence base consists primarily of animal studies with limited human clinical data
Advantages Sustained release: SubQ fat creates a depot effect, releasing the peptide gradually into circulation over time
The schedules of the entrances and transports could be subject to modifications